17 Apr 2021 12:16 IST

FORE gets patent grant by IP Australia for tech innovation

Development of the prototype of nail-fold capillaroscopy for early detection of diabetes wins patent

FORE School of Management, Delhi-NCR has recently announced the development of the prototype, inexpensive nail-fold capillaroscopy for early detection of cardio-metabolic disease. The firm shared that their innovation will help in the early detection of diabetes and that it has received a patent grant from IP Australia, one of the superior industry, innovation and science dedicated agency. Assistant Professor Vinaytosh Mishra, one of the expert faculty members of FORE is the ideator of this device in association with a highly skilled team of twelve proficient researchers and doctors.

Realising the severity linked with diabetes prompted FORE to initiate the development of this prototype. While it is a serious health concern at the global level, as per the organisation, India alone is home to the second-largest number of adults (approximately 77 million) suffering from diabetes. Hence, they brainstormed to develop a device that is tech-savvy and will aid in the detection of diabetes at an early stage.

With this technological innovation, the B-school aims to contribute their bit in combating the risk associated with diabetes. Understanding that the early detection of the disease plays a pivotal role in its management, Mishra wanted to develop a tool that will help in the same in the form of Diabetic Retinal Screening (DRS) at an affordable pricing.

Easy use

The proposed tool uses nail-fold capillaroscopy for early detection of vascular complications and diabetes. It is portable and economically priced which makes it ideal for mass screening of pre-diabetes. The device costs around $100 and can be used to screen more than 100 patients daily. It comes with an easy and convenient usage and can be handled easily by a non-clinical person as well after minimal training.

Expressing his elation on the same, Assistant Prof Vinaytosh Mishra, said, “This is a huge achievement for FORE and we are glad to have collaborated with a team of skilled professionals from the medical industry who have put in their heart and soul in the development of the tool. This device if utilised optimally and appropriately can turn out to be a boon by helping in the detection of diabetes at an early stage.”

With this device, the firm has added another feather in its cap and is a testimony of the fact that it will continue to up-scale the healthcare sector with its expertise and contributions.